AGN-199201

· Allergan

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for AGN-199201, covering 2013-11-15 to 2020-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia [Phase 2]